PT - JOURNAL ARTICLE AU - Fatemeh Rafiei Nasab AU - Fakher Rahim TI - Bibliometric Analysis of Global Scientific Research on SARS-CoV-2 (COVID-19) AID - 10.1101/2020.03.19.20038752 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.19.20038752 4099 - http://medrxiv.org/content/early/2020/03/23/2020.03.19.20038752.short 4100 - http://medrxiv.org/content/early/2020/03/23/2020.03.19.20038752.full AB - Background and Aim Since late 2019, an unknown-origin pneumonia outbreak detected in Wuhan city, Hubei Province, China. We aimed to build a model to qualitatively and quantitatively assess publications of research of COVID-19 from 2019 to 2020.Materials and Methods Data were obtained from the Web of Science (WOS), PubMed, and Scopus Core Collection on March 02, 2020, and updated on March 10. We conducted a qualitative and quantitative analysis of publication outputs, journals, authors, institutions, countries, cited references, keywords, and terms according to bibliometric methods using VOS viewer c software packages.Results Initially, we identified 227 papers, of which after an exclusion process, 92 studies were selected for statistical analyses. China accounted for the highest proportion of published research (44 papers, 40.48%), followed by the United States (21 papers, 19.32%), and Canada (7 papers, 6.44%). Adjusted by gross domestic product (GDP), ranked first, with 0.003 articles per billion GDP. In total, the top 10 journals published 47 articles, which accounted for 51.08% of all publications in this Feld. A total of 6 studies (05.52%) were supported by National Natural Science Foundation of China. Chinese Academy of Sciences ranked second 2, 2.76%).Conclusion Bibliometric and visualized mapping may quantitatively monitor research performance in science and present predictions. The subject of this study was the fast growing publication on COVID-19. Most studies are published in journals with very high impact factors (IFs) and other journals are more interested in this type of research.HighlightsBibliometric description and mapping provided a birds-eye view of information on Covid-19 related researchReaders to comprehend the history of published Covid-19 articles in just a few minutes.We evaluated the research strength of countries and institutions,Scholars might refer to in order to find cooperative institutions.During our research using the selected database, we tried to guarantee comprehension and objectivity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data presented in the manuscript.